M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and ...

These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

The centre will leverage fully automated lesion segmentation in PSMA-PET/CT imaging. Malaysia’s Sunway Medical Centre, Sunway ...

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Get the latest from The ...

Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug ...

American Oncology Institute (AOI) in collaboration with Nangia Specialty Hospital in Nagpur, has introduced the advanced Gallium generator marking a new chapter in precision medicine. It will enable ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...

The firm will pay $45 million upfront for several new targeted agents that it plans to pair with isotopes to develop both ...

How do we identify non-responders to 177 Lu-PSMA using PSMA PET? There have been numerous scores/classification systems identified, including the VISION PET criteria, HIT score, PSG score, and ...